These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 1376704

  • 1. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
    Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML.
    Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR, McDaniel ML.
    Biochem J; 1992 Oct 01; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of nitric oxide formation by guanidines.
    Hasan K, Heesen BJ, Corbett JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BH, Williamson JR, Tilton RG.
    Eur J Pharmacol; 1993 Nov 02; 249(1):101-6. PubMed ID: 7506664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo.
    Laszlo F, Evans SM, Whittle BJ.
    Eur J Pharmacol; 1995 Jan 16; 272(2-3):169-75. PubMed ID: 7536162
    [Abstract] [Full Text] [Related]

  • 15. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
    Laychock SG, Modica ME, Cavanaugh CT.
    Endocrinology; 1991 Dec 16; 129(6):3043-52. PubMed ID: 1683279
    [Abstract] [Full Text] [Related]

  • 16. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
    Griffiths MJ, Messent M, MacAllister RJ, Evans TW.
    Br J Pharmacol; 1993 Nov 16; 110(3):963-8. PubMed ID: 7507781
    [Abstract] [Full Text] [Related]

  • 17. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
    Xenos ES, Stevens RB, Sutherland DE, Lokeh A, Ansite JD, Casanova D, Gores PF, Platt JL.
    Transplantation; 1994 Apr 27; 57(8):1208-12. PubMed ID: 8178348
    [Abstract] [Full Text] [Related]

  • 18. Effects of endothelin-1 and inhibition of nitric oxide production with NG-monomethyl-L-arginine on arterial pressure and regional blood flow in anesthetized rats.
    Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M.
    J Cardiovasc Pharmacol; 1992 Apr 27; 20 Suppl 12():S176-8. PubMed ID: 1282961
    [Abstract] [Full Text] [Related]

  • 19. Effects of guanidino and uremic compounds on nitric oxide pathways.
    MacAllister RJ, Whitley GS, Vallance P.
    Kidney Int; 1994 Mar 27; 45(3):737-42. PubMed ID: 7515129
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y, Miura Y, Yamamoto N, Ozaki N, Oiso Y.
    Diabetologia; 2003 Sep 27; 46(9):1228-33. PubMed ID: 12898012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.